MYOF and pancreatic adenocarcinoma: Using our internal PAAD patient cohort, we quantified stromal myoferlin staining ranging from weak to intense and segregated patients in MYOFhigh stroma vs MYOFlow stroma (Fig. 1I), while demographic and clinical parameters were homogenous between groups (Fig. EV1J).